Avatar
Business Insider News source @businessinsider.com · New York City 🇺🇸· 3w

#UndercoverAgent #WeightLossJourney #MafiaInfiltration

Link Preview
www.businessinsider.com
Former FBI undercover agent says weighing over 400 pounds was his best disguise
The only issue is that, unlike other disguises, being overweight doesn't come off overnight. Joaquin Garcia spent 24 years as an undercover agent for the FBI.
W
Washington Post News source @washingtonpost.com · Washington (state) 🇺🇸· 3w

#WeightLossDrugs #PharmaceuticalPricing #HealthcareAccessibility

Link Preview
www.washingtonpost.com
How GLP1s are changing the ways Americans buy medicine
Ashley Elizabeth Harden logged on recently from her home in small-town Louisiana and searched for a weight-loss drug. She found plenty of options and settled on a cheaper, imitation version of the name-brand drugs for $177 a month that she could buy without going through insurance.
Avatar
New York Post News source @nypost.com · New York City 🇺🇸· 4w

#KetoDiet #WeightLoss #GutHealth

Link Preview
nypost.com
New 'keto pill' mimics popular diet without giving up carbs
Keto is a high-fat, moderate-protein and low-carb diet designed to plunge the body into ketosis, where it burns fat instead of carbs for fuel.
W
Washington Post News source @washingtonpost.com · Washington (state) 🇺🇸· 4w

#WeightLoss #BoneHealth #GLP1

Link Preview
www.washingtonpost.com
GLP-1 drugs like Ozempic can raise bone and tendon injury risk, study suggests
The miracle of rapid weight loss has always come with fine print. Until recently, it read mostly like a list of digestive complaints -- stomach aches, constipation -- generally unpleasant but tolerable and rarely severe.
Avatar
New York Post News source @nypost.com · New York City 🇺🇸· 4w

#WeightLossDrugs #HeartHealth #GLP1

Link Preview
nypost.com
Ozempic-style drugs could slash complication risks after heart...
A popular class of weight-loss drugs may prevent life-threatening cardiac complications by opening microscopic blood vessels that often remain blocked after a heart attack, according to a study published this week in Nature Communications.
Avatar
Yahoo News source @yahoo.com · Sunnyvale, California 🇺🇸· Mar 5

#WeightLoss #AddictionTreatment #SubstanceAbuse

Link Preview
www.yahoo.com
Wegovy and Mounjaro could treat addiction to alcohol, tobacco, drugs
Add Yahoo as a preferred source to see more of our stories on Google. Weight-loss jabs could prevent and treat addiction to alcohol, cigarettes and drugs, according to a large study.
Avatar
CNN International News source @edition.cnn.com · Atlanta, Georgia 🇺🇸· Mar 5

#GLP1 #AddictionTreatment #WeightLossMedications

Link Preview
edition.cnn.com
Could popular weight loss drugs become the new treatment for addiction? Evidence is starting to mount
Evidence is mounting that the wildly popular weight-loss medicines known as GLP-1s may also hold potential for treating addiction, and the field may be on the verge of obtaining desperately needed answers through more study.
Avatar
CNN News source @us.cnn.com · United States 🇺🇸· Mar 5

#GLP1 #AddictionTreatment #WeightLossMedication

Link Preview
us.cnn.com
Could popular weight loss drugs become the new treatment for addiction? Evidence is starting to mount | CNN
Evidence is mounting that the wildly popular weight-loss medicines known as GLP-1s may also hold potential for treating addiction, and the field may be on the verge of obtaining desperately needed answers through more study.
Avatar
New York Post News source @nypost.com · New York City 🇺🇸· Mar 2

#GLP1 #Osteoporosis #WeightLoss

Link Preview
nypost.com
Drugs like Ozempic can increase your risk of a silent but serious...
The benefits of GLP-1 drugs like Ozempic are myriad, from weight loss to improved cardiovascular health to potentially preventing dementia, lowering the risk of depression, and reducing the intensity of migraines.
Avatar
New York Post News source @nypost.com · New York City 🇺🇸· Mar 1

#GLP1 #Migraines #WeightLoss

Link Preview
nypost.com
Drugs like Ozempic may have a surprising benefit: study
Numerous additional benefits of GLP-1 weight loss drugs like Ozempic continue to be discovered, from improving cardiovascular health to potentially preventing dementia and lowering the risk of depression.
Avatar
The New York Times News source @nytimes.com · New York City 🇺🇸· Feb 26

#Ozempic #WeightLoss #HealthCare

Link Preview
www.nytimes.com
Game-Changing Drugs
Ozempic and similar weight-loss medications are hailed as miracle drugs. But there are plenty of unknowns about long-term use.
Avatar
Yahoo News source @yahoo.com · Sunnyvale, California 🇺🇸· Feb 26

#Diabetes #WeightLoss #MedicalResearch

Link Preview
www.yahoo.com
Researchers discover new benefit of once-a-day weight loss pill
Add Yahoo as a preferred source to see more of our stories on Google. Researchers have hailed the results of a new study on a once-a-day weight loss pill as an "important advancement" in type 2 diabetes care.
Avatar
Business Insider News source @businessinsider.com · New York City 🇺🇸· Feb 26

#GLP1 #WeightLoss #DiabetesManagement

Link Preview
www.businessinsider.com
Eli Lilly is set to release a once-daily pill to rival Ozempic this year. People are losing 15 to 20 pounds on it, but there's a catch.
The pill, which analysts say might cost $300 a month, could be available as soon as mid-2026. Better injections and better pills.
Avatar
New York Post News source @nypost.com · New York City 🇺🇸· Feb 26

#GLP1 #WeightLoss #SexualHealth

Link Preview
nypost.com
Exclusive | We lost weight on GLP-1 drugs -- and then we lost our sex drives
Welcome to The Thin Line, The New York Post's series about the darker side of GLP-1 drugs. Though GLP-1 agonists sold under brand names like Ozempic have helped millions of people lose weight, manage diabetes and improve other health conditions, they are not without risks.
Avatar
CNN News source @us.cnn.com · United States 🇺🇸· Feb 24

#Pharmaceuticals #WeightLoss #DiabetesMedication

Link Preview
us.cnn.com
Novo Nordisk to slash Ozempic and Wegovy list prices by up to 50% for 2027 | CNN
Battling to regain its market share over rival Eli Lilly, Novo Nordisk announced Tuesday that it will reduce the list prices of its popular weight loss drug Wegovy and diabetes drugs Ozempic and Rybelsus by up to half starting in 2027.
Avatar
Yahoo News source @yahoo.com · Sunnyvale, California 🇺🇸· Feb 24

#ObesityTreatment #WeightLoss #FDAApproval

Link Preview
www.yahoo.com
FDA approves Allurion's PMA application for Gastric Balloon System
Allurion's founder and CEO Dr Shantanu Gaur stated that the Smart Capsule offers a safe and effective alternative to GLP-1s and bariatric surgery, aiming to provide metabolically healthy weight loss and become a standard tool in obesity treatment in the US.
Avatar
New York Post News source @nypost.com · New York City 🇺🇸· Feb 18

#WeightLoss #DiabetesTreatment #GLP1

Link Preview
nypost.com
People dropped out of Eli Lilly's new GLP-1 drug trial because they...
Participants taking the highest dose of Eli Lilly's new GLP-1 drug lost an average of 28. 7% of their body weight in a late-stage trial, putting it on track to be a heavyweight in the crowded world of weight-loss and diabetes treatments.
Avatar
Yahoo! News source @ca.style.yahoo.com · Sunnyvale, California 🇺🇸· Feb 18

#Zepbound #Psoriasis #WeightLoss

Link Preview
ca.style.yahoo.com
Lilly's Zepbound and Taltz improve psoriasis symptoms, drive weight loss in study
Feb 18 (Reuters) - Eli Lilly said on Wednesday its weight-loss drug, Zepbound, used with psoriasis treatment Taltz, showed better results in patients with the skin disease and obesity in a late-stage study, compared to Taltz alone.
Avatar
Fox News News source @foxnews.com · New York City 🇺🇸· Feb 18

#BodyPositivity #Health #WeightLoss

Link Preview
www.foxnews.com
Former body positivity influencer says movement became 'radical,' admits feeling 'brainwashed'
Dave Danna said the body positivity movement is promoting unhealthy lifestyles after losing nearly 60 pounds over the past six months on his own health journey.
Avatar
Yahoo! Finance News source @ca.finance.yahoo.com · United States 🇺🇸· Feb 7

#WeightLoss #HealthcareAdvertising #SuperBowlAds

Link Preview
ca.finance.yahoo.com
Weight-loss drugs to compete on biggest stage with Super Bowl ads
NEW YORK, Feb 7 (Reuters) - Companies looking to sell weight-loss drugs directly to consumers, including Novo Nordisk's Wegovy, will shell out millions of dollars for celebrity-filled ads during Sunday's Super Bowl with its promise of one of the year's largest global audiences.